Skip to Main Content

Paper Details

Single-cell technologies - studying rheumatic diseases one cell at a time.
Nat Rev Rheumatol
25
2019
immune cells, pathologically important cells, patients, rheumatic, rheumatic diseases, single, single cells
Author NameAffiliation
Peggie CheungInstitute for Immunity, Stanford University School of Medicine
Peggie CheungStanford University School of Medicine
Purvesh KhatriInstitute for Immunity, Stanford University School of Medicine
Purvesh KhatriStanford University School of Medicine
Purvesh KhatriInstitute for Immunity, Stanford University School of Medicine
Purvesh KhatriStanford University School of Medicine
Paul J UtzInstitute for Immunity, Stanford University School of Medicine
Paul J UtzStanford University School of Medicine
Alex J KuoInstitute for Immunity, Stanford University School of Medicine
Alex J KuoStanford University School of Medicine
  • 1 - 10

Datasets

Release 1.2